0

Your cart is empty

Alluvi Retatrutide 40mg Pen

Alluvi Retatrutide 40mg Pen

Alluvi Retatrutide 40mg pen is drawing global attention as a potential next-generation weight-loss injection.
Developed from Eli Lilly’s investigational molecule Retatrutide (LY3437943), it activates GLP-1, GIP, and glucagon receptors—three key pathways that influence appetite, metabolism, and energy balance.

£155.00

You will earn 310 points worth £1.55 for each quantity you will order

Quantity

Reviews

0.00

0 Reviews
5 Star
0
4 Star
0
3 Star
0
2 Star
0
1 Star
0

No reviews yet. Be the first to review this product!


Search Products